About Paul Korner
Form D filings for Voltron Therapeutics from 2021 to 2023 list Paul Korner as director.
Paul Korner first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Paul Korner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Paul Korner works with at each company, as listed on that company's latest Form D.
Voltron Therapeutics, Inc. · Form D/A, Nov 9, 2023
ME
Matthew Eitner
Director
JA
James Ahern
Director
AZ
Anthony Zook
Director
MD
Matthew Duffy
President and director
PG
Patrick Gallagher
Chief Executive Officer and director